Filing Details
- Accession Number:
- 0001209191-15-061694
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-20 17:02:27
- Reporting Period:
- 2015-07-17
- Filing Date:
- 2015-07-20
- Accepted Time:
- 2015-07-20 17:02:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1571865 | W. Timothy Trost | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713 | Svp, Cfo & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-07-17 | 28,000 | $2.35 | 37,850 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-07-17 | 28,000 | $50.00 | 9,850 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common | Stock Option (Right to Buy) | Disposition | 2015-07-17 | 28,000 | $0.00 | 28,000 | $2.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
78,461 | 2021-04-06 | No | 4 | M | Direct |
Footnotes
- Includes 678 shares of Common Stock that were acquired by the Reporting Person on March 10, 2015 pursuant to the Issuer's Employee Stock Purchase Plan.
- The sales reported in the Form 4 were effected pursuant to a Rule 10B5-1 Plan adopted by the reporting person on September 5, 2013.
- In accordance with its terms, the shares underlying the option are subject to vesting as follows: 1/4th of the shares vest one year after July 26, 2010; the remainder of the shares vest in equal monthly installments thereafter over the next three years.